Code Infusion And Chemotherapy - Certified Professional Coder CPC

1. Which CPT® code is reported for this intramuscular injection?
   Answer: 96372 CPT® 96372 describes therapeutic, prophylactic, or diagnostic injection into subcutaneous or intramuscular tissue — the correct code for any IM or SC injection of a non-chemotherapy drug administered in a clinical setting. Penicillin G benzathine is an antibiotic (not a chemotherapy agent), administered intramuscularly, making 96372 appropriate. Code 96374 describes an intravenous push; the route here is intramuscular, not intravenous. Code 96401 describes chemotherapy administration by the subcutaneous or intramuscular route; penicillin is not a chemotherapy or antineoplastic agent. Code 96369 describes a subcutaneous infusion (pump-delivered) for therapeutic purposes lasting up to 1 hour; this is a single injection, not a subcutaneous infusion. Code 96372 applies to all IM and SC injections of non-chemotherapy therapeutic, prophylactic, or diagnostic substances.
2. May the concurrent normal saline hydration be separately reported in addition to the primary chemotherapy infusion?
   Answer: No, concurrent hydration is not separately reportable when a more complex infusion service is the primary service Per CPT® infusion guidelines, hydration (96360/96361) administered concurrently with or as a secondary service to a primary therapeutic or chemotherapy infusion is not separately reportable. Hydration that exists solely to support the administration of the primary drug (vein patency, prehydration, post-hydration as part of the chemotherapy protocol) is considered incidental to the primary infusion service and is bundled into it. Modifier 59 does not override this bundling rule when the hydration is not a distinct, separately indicated service. Code 96361 is an add-on for hydration-only encounters, not for concurrent hydration during a more complex service. Code 96368 applies to concurrent infusion of a different drug substance, not plain hydration fluid without a distinct therapeutic purpose. Hydration is only separately reportable when it is the primary or standalone service of the encounter.
3. Which CPT® code is reported for this chemotherapy injection?
   Answer: 96401 CPT® 96401 describes chemotherapy administration by subcutaneous or intramuscular injection of a non-hormonal antineoplastic agent — the correct code when a chemotherapy drug is administered by the IM or SC route. Methotrexate at high doses for acute leukemia is an antineoplastic chemotherapy agent given by intramuscular injection, requiring the chemotherapy-specific administration code. Code 96372 describes IM or SC injection of a non-chemotherapy therapeutic substance; CPT guidelines specify that chemotherapy administration must be reported with the chemotherapy codes (9640x series), not the general injection codes. Code 96365 describes IV infusion; the route here is intramuscular, not intravenous. Code 96409 describes chemotherapy administered as an IV push; the route here is IM. When any recognized antineoplastic chemotherapy drug is administered, the chemotherapy administration hierarchy applies.
4. Which add-on CPT® code is reported for each additional hour of hydration beyond the first hour?
   Answer: 96361 CPT® 96361 describes intravenous infusion for hydration, each additional hour (add-on to 96360) — the correct add-on code for every additional hour of plain IV fluid hydration beyond the initial 31-to-60-minute period captured by 96360. For a total hydration time of 1 hour 45 minutes, the reporting is 96360 (initial, 31 to 60 min) plus one unit of 96361 (for the additional 45 minutes beyond the first hour). Code 96360 is the primary hydration code and cannot be reported as an add-on. Code 96366 is the add-on for additional hours of therapeutic infusion (non-hydration); plain saline without medication is hydration, not therapeutic infusion. Code 96365 is the primary therapeutic infusion code. CPT® 96361 is an add-on code and must always be reported in conjunction with 96360 as the primary code.
5. Which CPT® code reports the mesna as a sequential non-chemotherapy infusion following the primary chemotherapy?
   Answer: 96367 CPT® 96367 describes additional sequential infusion of a new drug or substance different from the primary service substance, up to 1 hour — the add-on code used when a non-chemotherapy drug is infused sequentially after any primary infusion (including chemotherapy). Mesna is not a chemotherapy agent; it is a uroprotective drug given after cyclophosphamide. Since mesna is administered sequentially after the chemotherapy ends, 96367 is the appropriate add-on code even when the primary infusion was chemotherapy (96413). Code 96365 is a primary therapeutic infusion code, not an add-on; when chemotherapy is the primary service, non-chemo drugs given sequentially use 96367 as the add-on. Code 96366 describes additional hours of the same primary therapeutic drug; mesna is a different drug. Code 96415 is the chemotherapy-specific add-on for additional hours of the same chemo drug; mesna is not a chemotherapy drug.
6. Which CPT® code is reported for this intramuscular injection?
   Answer: 96372 CPT® 96372 describes therapeutic, prophylactic, or diagnostic injection — subcutaneous or intramuscular — the correct code for any IM or SC injection of a non-chemotherapy substance. Promethazine is an antiemetic medication (not chemotherapy) administered by the intramuscular route, making 96372 the appropriate code. Code 96374 describes an IV push; no intravenous access is established and the drug is given intramuscularly, not intravenously. Code 96369 describes subcutaneous infusion via pump delivery over time; this is a single injection, not a pump-driven subcutaneous infusion. Code 96365 describes IV infusion; the route here is intramuscular. Code 96372 covers the broadest range of single-injection services for non-chemotherapy drugs regardless of the IM or SC route.
7. Which CPT® code is reported for this IV push administration?
   Answer: 96374 CPT® 96374 describes a therapeutic, prophylactic, or diagnostic intravenous push, single or initial substance — the correct code when a drug is administered directly into a vein or into an established IV line over 15 minutes or less. Ondansetron is administered over 5 minutes, well within the 15-minute threshold for an IV push. Code 96365 describes an IV infusion lasting more than 15 minutes; this administration is 5 minutes, falling within push criteria. Code 96368 describes a concurrent infusion of a different drug administered simultaneously with a primary infusion; there is no concurrent primary infusion running here. Code 96372 describes a subcutaneous or intramuscular injection; the route here is intravenous push. The 15-minute boundary is the key rule separating IV push (96374, 15 min or less) from IV infusion (96365, more than 15 minutes).
8. Which CPT® code is reported for this IV hydration service?
   Answer: 96360 CPT® 96360 describes intravenous infusion for hydration, initial, 31 minutes to 1 hour — the correct code when plain intravenous fluid (without medication) is administered for hydration purposes and the infusion lasts between 31 and 60 minutes. Code 96365 describes the initial hour of a therapeutic, prophylactic, or diagnostic IV infusion of a drug or substance; plain normal saline without added medication is not a therapeutic drug infusion. Code 96361 is the add-on code for each additional hour of hydration beyond the first hour; it cannot be reported as a standalone code. Code 96366 is the add-on code for each additional hour of therapeutic infusion; it also cannot be reported as a primary code. The key distinction between 96360 and 96365 is that 96360 is for plain fluid hydration with no medication, while 96365 applies when a drug or other therapeutic substance is being infused.
9. Per CPT® infusion hierarchy rules, which code is reported as the primary service for this encounter?
   Answer: 96413 CPT® 96413 is reported as the primary service because chemotherapy administration is the highest level in the infusion service hierarchy and takes primary code precedence regardless of the order in which drugs are administered during the encounter. When chemotherapy and non-chemotherapy infusion services occur in the same session, the chemotherapy code (96413) is always the primary code. Ondansetron is then reported as the sequential infusion add-on (96367) even though it was given first. Code 96365 may not be reported as the primary when chemotherapy is administered in the same encounter. Reporting both 96365 and 96413 as co-primary codes is incorrect per CPT® hierarchy guidelines. The hierarchy order is: chemotherapy administration (highest) > therapeutic/prophylactic/diagnostic infusion > hydration (lowest). The drug with the highest service level drives the primary code selection.
10. Which CPT® code is reported as the primary service for this encounter?
    Answer: 96360 CPT® 96360 describes intravenous infusion for hydration, initial, 31 minutes to 1 hour — the correct primary code when plain IV fluid (without medication) is administered for hydration and the infusion time is between 31 and 60 minutes. Lactated Ringer solution without added medication is a hydration fluid. Code 96365 describes initial IV infusion of a therapeutic, prophylactic, or diagnostic drug substance; plain IV fluid without medication does not constitute a therapeutic drug infusion. Code 96361 is an add-on code (each additional hour of hydration) and cannot function as a standalone primary code. Code 96366 is an add-on code for each additional hour of therapeutic infusion. For this encounter, the infusion time (40 minutes) falls squarely in the 31-to-60-minute window for 96360, and no medication is administered, confirming 96360 as the sole reportable code.
11. Which add-on CPT® code is reported for each additional hour of chemotherapy infusion beyond the first hour?
    Answer: 96415 CPT® 96415 describes chemotherapy administration by intravenous infusion, each additional hour (add-on to 96413) — the correct code for every hour of chemotherapy infusion beyond the first hour already captured by 96413. Code 96415 is an add-on code and may only be reported in conjunction with 96413 as the primary service. Code 96366 describes each additional hour of a non-chemotherapy therapeutic infusion (add-on to 96365); since oxaliplatin is a chemotherapy agent, the chemotherapy-specific add-on (96415) must be used. Code 96417 describes an additional sequential chemotherapy infusion of a new drug/substance — not an additional hour of the same drug. Code 96367 describes sequential infusion of a different non-chemo substance. For a 2-hour oxaliplatin infusion, the correct reporting is 96413 for the first hour plus one unit of 96415 for the second hour.
12. Which add-on CPT® code is reported for the second and third hours of the infliximab infusion?
    Answer: 96366 CPT® 96366 describes intravenous infusion for therapy/prophylaxis/diagnosis, each additional hour (add-on to 96365) — the correct add-on code for every hour of the same drug's infusion beyond the first hour captured by 96365. For a 3-hour infliximab infusion, the correct reporting is 96365 (initial first hour) plus two units of 96366 (second and third hours). Code 96367 describes additional sequential infusion of a different new drug; both the second and third hours involve the same drug (infliximab), not a different drug. Code 96368 describes concurrent infusion of a different drug running simultaneously; additional hours of the same drug is not concurrent infusion. Code 96415 is the chemotherapy-specific add-on for additional hours; infliximab is a biologic agent, not an antineoplastic chemotherapy drug, so 96366 is appropriate rather than 96415.
13. Which CPT® code is reported for this initial chemotherapy IV push?
    Answer: 96409 CPT® 96409 describes chemotherapy administration by IV push, single or initial substance — the correct code when a chemotherapy drug is directly injected into a vein or established line over 15 minutes or less. Vincristine is an antineoplastic vinca alkaloid administered over 10 minutes, meeting both the chemotherapy and IV push criteria. Code 96374 describes IV push of a non-chemotherapy therapeutic drug; vincristine is a chemotherapy agent, and CPT guidelines require use of the chemotherapy-specific push code (96409) rather than the general therapeutic push code. Code 96413 describes chemotherapy administered by IV infusion over more than 15 minutes; vincristine is given over 10 minutes, classifying it as a push rather than an infusion. Code 96411 is the add-on for additional sequential chemotherapy IV push of a different drug; it cannot be reported without a primary 96409 and does not apply as a standalone initial code.
14. Which CPT® code is reported for the initiation of this prolonged chemotherapy infusion requiring a portable pump?
    Answer: 96416 CPT® 96416 describes initiation of prolonged chemotherapy infusion requiring more than 8 hours, requiring use of a portable or implantable pump — the correct code for programming and starting an extended continuous chemotherapy infusion when the patient carries the pump home. A 46-hour 5-FU infusion via ambulatory pump is the most common clinical example. Code 96413 describes initial chemotherapy infusion up to 1 hour; it is not used when the infusion is designed as a continuous prolonged (>8 hour) pump-delivered infusion. Code 96415 is the add-on for additional hours of IV chemotherapy infusion; it applies to in-office infusions, not pump-initiated take-home infusions. Code 96417 describes sequential chemotherapy infusion of a different drug. For prolonged continuous chemotherapy infusions exceeding 8 hours that require a portable or implantable pump, 96416 is the correct standalone code.
15. Which CPT® code reports the docetaxel as a sequential chemotherapy infusion of a different drug?
    Answer: 96417 CPT® 96417 describes additional sequential chemotherapy infusion of a new drug or substance, up to 1 hour (add-on to 96413) — the correct add-on code when a second chemotherapy drug is infused sequentially after the primary chemotherapy infusion ends. Docetaxel is a chemotherapy agent administered sequentially (not concurrently) after carboplatin, requiring the chemotherapy-specific sequential add-on code. Code 96367 describes additional sequential infusion of a non-chemotherapy drug; docetaxel is a chemotherapy agent, requiring 96417, not 96367. Code 96415 describes additional hours of the same chemotherapy drug (not a new drug); docetaxel is a different chemotherapy drug from carboplatin. Code 96413 is the primary chemotherapy infusion code; it may not be used again as an add-on for a second drug in the same session — 96417 is the designated add-on for sequential different-drug chemo infusions.
16. Which add-on CPT® code reports the dexamethasone as a sequential IV push of a different drug?
    Answer: 96375 CPT® 96375 describes each additional sequential IV push of a new drug or substance, different from the drug reported as the initial push — the correct add-on code when a second drug is given as a separate IV push in sequence after the initial push is complete. Dexamethasone is a different drug from ondansetron, administered sequentially (not simultaneously), making 96375 the correct add-on to the primary 96374. Code 96374 is the primary IV push code and may not be repeated for a second different drug in the same session; the add-on 96375 captures subsequent different-drug pushes. Code 96376 describes an additional sequential IV push of the same drug (identical substance); dexamethasone and ondansetron are different drugs. Code 96368 describes a concurrent (simultaneous) infusion, not a sequential push. The key differentiators: 96375 = different drug, sequential push; 96376 = same drug, sequential push (>30 min interval).
17. Which CPT® code is reported for this initial IV drug infusion?
    Answer: 96365 CPT® 96365 describes the initial intravenous infusion of a therapeutic, prophylactic, or diagnostic drug or substance, up to 1 hour — the correct code when a medication (methylprednisolone) is administered by infusion over a period greater than 15 minutes. Code 96360 describes IV hydration with plain fluid only; methylprednisolone is a therapeutic medication, not a hydration fluid. Code 96374 describes an IV push, which applies when a drug is administered in 15 minutes or less; the methylprednisolone is infused over 50 minutes, making 96365 appropriate. Code 96372 describes a subcutaneous or intramuscular injection; the route here is intravenous infusion. CPT guidelines define an infusion as a drug administered over more than 15 minutes; services of 15 minutes or less are reported as an IV push.
18. Which CPT® code is reported for the initial 1-hour paclitaxel chemotherapy infusion?
    Answer: 96413 CPT® 96413 describes chemotherapy administration by intravenous infusion, initial, up to 1 hour — the correct code for the first hour of any IV infusion of a chemotherapy agent. Paclitaxel is an antineoplastic chemotherapy drug administered by intravenous infusion, which requires a chemotherapy-specific administration code rather than a generic therapeutic infusion code. Code 96365 describes initial IV infusion of a non-chemotherapy therapeutic substance; chemotherapy administration codes (9640x/9641x series) take precedence and must be used for antineoplastic agents. Code 96401 describes chemotherapy administration by the subcutaneous or intramuscular route; paclitaxel is given intravenously here. Code 96409 describes chemotherapy given as an IV push (15 minutes or less); the paclitaxel infusion runs over 1 hour, requiring 96413.
19. Which add-on CPT® code reports the second administration of the same drug as a sequential IV push?
    Answer: 96376 CPT® 96376 describes each additional sequential IV push of the same drug or substance at intervals of greater than 30 minutes from the prior push — the correct add-on code when the identical drug is re-administered by IV push after a gap of more than 30 minutes from the initial push. Both the drug identity (metoclopramide) and the time interval (75 minutes after the first push) satisfy the criteria for 96376. Code 96374 is the primary IV push code and may not be reported again for a second push of the same drug in the same session; the add-on code 96376 is used instead. Code 96375 describes a sequential IV push of a different drug — the second push here is the same drug (metoclopramide), not a different drug. Code 96367 describes sequential IV infusion (not push) of a different substance. The 30-minute interval and same-drug identity are the dual criteria for 96376.
20. What is the minimum documented infusion duration required to report CPT® 96360 (IV hydration, initial)?
    Answer: Greater than 30 minutes CPT® 96360 (IV hydration, initial) requires a minimum documented infusion duration of greater than 30 minutes — specifically, the code descriptor states "31 minutes to 1 hour." Any hydration-only infusion of 30 minutes or less does not meet the minimum threshold and is not separately reportable under any hydration code; there is no IV push code for plain hydration fluid. By contrast, for therapeutic drug infusions (96365), the minimum is greater than 15 minutes — services of 15 minutes or less are reported as an IV push (96374). The 31-minute threshold applies specifically to the hydration code (96360), while the 15-minute boundary separates push from infusion for therapeutic drugs. These are two distinct rules for two distinct code families and should not be conflated.

Start this quiz